Piramal Pharma will focus on policy actions amid tariff concerns. Its global manufacturing network offers a significant advantage. The comp...

Laurus Labs reported a strong June-quarter performance, with net profit more than doubling and revenue rising 29% year-on-year, driven by r...

There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

Biocon will delay its Indian launch of semaglutide. The company is focusing on international markets for the diabetes and weight-management...

India's obesity drug market is experiencing rapid growth, driven by rising lifestyle diseases and the launch of blockbuster therapies. The ...

India’s generic pharma faces tariff uncertainty but retains edge in US market: JPMorgan analyst

Indian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring trend and a desir...

Exporters can pass on cost increases to consumers, and the favourable USD/INR exchange rate and increased outsourcing opportunities are exp...

Anthem Biosciences, a CRDMO, has filed for a Rs 3,395 crore IPO. The offer comprises an OFS by promoters and investors, including True Nort...

Suven Pharmaceuticals, backed by Advent International, is eyeing further mergers and acquisitions to bolster its capabilities and order boo...

Syngene International, the contract research and manufacturing services arm of Biocon reported a 9% year-on-year (YoY) drop in net profit t...

Piramal Pharma aims to achieve $2 billion in annual revenue with a 25% operating margin by fiscal 2030, driven by its CDMO business. The co...

The company witnessed multiple challenges related to macroeconomic factors during and after COVID-19, high attrition at European manufactur...

India is expected to see an upward trajectory in deal activity in 2024, according to a report by Bain & Company's Global Healthcare Private...

This approach can prove to be effective against emerging Covid variants.

Kolkata, Dec 9 (IANS) Opening up new horizons in designing drugs for Alzheimer's disease, Indian researchers have discovered that fibrinoge...